[1]
|
Liu, X., Xing, H. and Liu, B. (2022) Current Status and Future Perspectives of Immune Checkpoint Inhibitors in Extensive-Stage Small Cell Lung Cancer. American Journal of Cancer Research, 12, 2447-2464.
|
[2]
|
Guo, H., Li, L. and Cui, J. (2020) Advances and Challenges in Immunotherapy of Small Cell Lung Cancer. Chinese Journal of Cancer Research, 32, 115-128. https://doi.org/10.21147/j.issn.1000-9604.2020.01.13
|
[3]
|
Yang, S., Zhang, Z. and Wang, Q. (2019) Emerging Therapies for Small Cell Lung Cancer. Journal of Hematology & Oncology, 12, Article No. 47. https://doi.org/10.1186/s13045-019-0736-3
|
[4]
|
Yang, H., Liu, Y., Chen, L., et al. (2023) miRNA-Based Therapies for Lung Cancer: Opportunities and Challenges? Biomolecules, 13, Article 877. https://doi.org/10.3390/biom13060877
|
[5]
|
Lei, Y., Chen, L., Liu, J., et al. (2022) The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy. Frontiers in Oncology, 12, Article 841625. https://doi.org/10.3389/fonc.2022.841625
|
[6]
|
Wani, J.A., Majid, S., Imtiyaz, Z., et al. (2022) MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential. Diagnostics (Basel), 12, Article 1610. https://doi.org/10.3390/diagnostics12071610
|
[7]
|
Pandey, M., Mukhopadhyay, A., Sharawat, S.K., et al. (2021) Role of MicroRNAs in Regulating Cell Proliferation, Metastasis and Chemoresistance and Their Applications as Cancer Biomarkers in Small Cell Lung Cancer. Biochimica et Biophysica Acta, 1876, Article 188552. https://doi.org/10.1016/j.bbcan.2021.188552
|
[8]
|
Rajgor, D., Sanderson, T.M., Amici, M., et al. (2018) NMDAR-Dependent Argonaute 2 Phosphorylation Regulates miRNA Activity and Dendritic Spine Plasticity. The EMBO Journal, 37, e97943. https://doi.org/10.15252/embj.201797943
|
[9]
|
Hutvagner, G., McLachlan, J., Pasquinelli, A.E., et al. (2001) A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the Let-7 Small Temporal RNA. Science, 293, 834-838. https://doi.org/10.1126/science.1062961
|
[10]
|
Sell, M.C., Ramlogan-Steel, C.A., Steel, J.C., et al. (2023) MicroRNAs in Cancer Metastasis: Biological and Therapeutic Implications. Expert Reviews in Molecular Medicine, 25, e14. https://doi.org/10.1017/erm.2023.7
|
[11]
|
Liu, Z.L., Wang, H., Liu, J., et al. (2013) MicroRNA-21 (miR-21) Expression Promotes Growth, Metastasis, and Chemo-or Radioresistance in Non-Small Cell Lung Cancer Cells by Targeting PTEN. Molecular and Cellular Biochemistry, 372, 35-45. https://doi.org/10.1007/s11010-012-1443-3
|
[12]
|
Takamizawa, J., Konishi, H., Yanagisawa, K., et al. (2004) Reduced Expression of the Let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival. Cancer Research, 64, 3753-3756. https://doi.org/10.1158/0008-5472.CAN-04-0637
|
[13]
|
Zhao, B., Han, H., Chen, J., et al. (2014) MicroRNA Let-7c Inhibits Migration and Invasion of Human Non-Small Cell Lung Cancer by Targeting ITGB3 and MAP4K3. Cancer Letters, 342, 43-51. https://doi.org/10.1016/j.canlet.2013.08.030
|
[14]
|
Liu, J., Liu, S., Deng, X., et al. (2019) MicroRNA-582-5p Suppresses Non-Small Cell Lung Cancer Cells Growth and Invasion via Downregulating NOTCH1. PLOS ONE, 14, e217652. https://doi.org/10.1371/journal.pone.0217652
|
[15]
|
Li, L., Song, W., Yan, X., et al. (2017) Friend Leukemia Virus Integration 1 Promotes Tumorigenesis of Small Cell Lung Cancer Cells by Activating the miR-17-92 Pathway. Oncotarget, 8, 41975-41987. https://doi.org/10.18632/oncotarget.16715
|
[16]
|
Zhou, R., Zhou, X., Yin, Z., et al. (2015) Tumor Invasion and Metastasis Regulated by MicroRNA-184 and MicroRNA-574-5p in Small-Cell Lung Cancer. Oncotarget, 6, 44609-44622. https://doi.org/10.18632/oncotarget.6338
|
[17]
|
Gao, F., Wu, H., Wang, R., et al. (2019) MicroRNA-485-5p Suppresses the Proliferation, Migration and Invasion of Small Cell Lung Cancer Cells by Targeting Flotillin-2. Bioengineered, 10, 1-12. https://doi.org/10.1080/21655979.2019.1586056
|
[18]
|
Cao, J., Song, Y., Bi, N., et al. (2013) DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer. Cancer Research, 73, 3326-3335. https://doi.org/10.1158/0008-5472.CAN-12-3055
|
[19]
|
Khan, P., Siddiqui, J.A., Kshirsagar, P.G., et al. (2023) MicroRNA-1 Attenuates the Growth and Metastasis of Small Cell Lung Cancer through CXCR4/FOXM1/RRM2 Axis. Molecular Cancer, 22, Article No. 1. https://doi.org/10.1186/s12943-022-01695-6
|
[20]
|
Mao, S., Lu, Z., Zheng, S., et al. (2020) Exosomal miR-141 Promotes Tumor Angiogenesis via KLF12 in Small Cell Lung Cancer. Journal of Experimental & Clinical Cancer Research, 39, Article No. 193. https://doi.org/10.1186/s13046-020-01680-1
|
[21]
|
Zhao, Z., Liu, J., Wang, C., et al. (2014) MicroRNA-25 Regulates Small Cell Lung Cancer Cell Development and Cell Cycle through Cyclin E2. International Journal of Clinical and Experimental Pathology, 7, 7726-7734.
|
[22]
|
Sun, Y., Hu, B., Wang, Y., et al. (2018) miR-216a-5p Inhibits Malignant Progression in Small Cell Lung Cancer: Involvement of the Bcl-2 Family Proteins. Cancer Management and Research, 10, 4735-4745. https://doi.org/10.2147/CMAR.S178380
|
[23]
|
Liu, H., Wu, X., Huang, J., et al. (2015) miR-7 Modulates Chemoresistance of Small Cell Lung Cancer by Repressing MRP1/ABCC1. International Journal of Experimental Pathology, 96, 240-247. https://doi.org/10.1111/iep.12131
|
[24]
|
Liu, H., Huang, J., Peng, J., et al. (2015) Upregulation of the Inwardly Rectifying Potassium Channel Kir2. 1 (KCNJ2) Modulates Multidrug Resistance of Small-Cell Lung Cancer under the Regulation of miR-7 and the Ras/MAPK Pathway. Molecular Cancer, 14, Article No. 59. https://doi.org/10.1186/s12943-015-0298-0
|
[25]
|
Cui, F., Hao, Z.X., Li, J., et al. (2020) SOX2 Mediates Cisplatin Resistance in Small-Cell Lung Cancer with Downregulated Expression of hsa-miR-340-5p. Molecular Genetics & Genomic Medicine, 8, e1195. https://doi.org/10.1002/mgg3.1195
|
[26]
|
Lai, J., Yang, H., Zhu, Y., et al. (2019) miR-7-5p-Mediated Downregulation of PARP1 Impacts DNA Homologous Recombination Repair and Resistance to Doxorubicin in Small Cell Lung Cancer. BMC Cancer, 19, Article No. 602. https://doi.org/10.1186/s12885-019-5798-7
|
[27]
|
Yang, X., Bai, F., Xu, Y., et al. (2017) Intensified Beclin-1 Mediated by Low Expression of miR-30a-5p Promotes Chemoresistance in Human Small Cell Lung Cancer. Cellular Physiology and Biochemistry, 43, 1126-1139. https://doi.org/10.1159/000481754
|
[28]
|
Pan, B., Chen, Y., Song, H., et al. (2015) miR-24-3p Downregulation Contributes to VP16-DDP Resistance in Small-Cell Lung Cancer by Targeting ATG4A. Oncotarget, 6, 317-331. https://doi.org/10.18632/oncotarget.2787
|
[29]
|
Yu, Y., Zuo, J., Tan, Q., et al. (2017) Plasma miR-92a-2 as a Biomarker for Small Cell Lung Cancer. Cancer Biomarkers, 18, 319-327. https://doi.org/10.3233/CBM-160254
|
[30]
|
Yan, H., Xin, S., Ma, J., et al. (2019) A Three MicroRNA-Based Prognostic Signature for Small Cell Lung Cancer Overall Survival. Journal of Cellular Biochemistry, 120, 8723-8730. https://doi.org/10.1002/jcb.28159
|